ResMed Stock Outlook: Is Wall Street Bullish or Bearish?

Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders. It is valued at a market cap of $37.3 billion. 

This healthcare company has outperformed the broader market over the past 52 weeks. Shares of RMD have rallied 12.8% over this time frame, while the broader S&P 500 Index ($SPX) has gained 11.9%. Moreover, on a YTD basis, the stock is up 8.3%, compared to SPX’s marginal drop.